StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.28−0.08 (-2.35%)

Close on Nov 20, 2026Market cap $6.59MP/E –Yield –

Quoin Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2020 it was -$1.44M.

Annual free cash flow

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$1.44M–
FY2019Dec 31, 2019-$1.33M–
FY2017Dec 31, 2017-$5.20M–

More Quoin Pharmaceuticals figures

See a number that looks wrong?